International Isotopes (INIS) insider granted 500k options at $0.06
International Isotopes Inc. (INIS) reported an insider transaction on a Form 4.
Rhea-AI Filing Summary
International Isotopes Inc. (INIS) reported an insider transaction on a Form 4. A reporting person who is both a Director and 10% Owner was granted a stock option to purchase 500,000 shares of common stock at an exercise price of $0.06 per share on 10/10/2025 (transaction code A).
The option becomes exercisable on 07/11/2026 and expires on 10/10/2035. Following the transaction, the insider beneficially owned 500,000 derivative securities, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 500,000 shares
Grant/Award
1 txn
Insider
GROSSO CHRISTOPHER G
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 500,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 500,000 contracts (Direct)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did INIS disclose in this Form 4?
A Director and 10% Owner received a grant of 500,000 stock options at a $0.06 exercise price on 10/10/2025.
What is the exercise price and timing for the INIS options?
The exercise price is $0.06 per share; the options become exercisable on 07/11/2026 and expire on 10/10/2035.
How many derivative securities does the insider own after the transaction?
Following the grant, the insider beneficially owned 500,000 derivative securities.
What is the insider’s relationship to INIS?
The reporting person is a Director and a 10% Owner of International Isotopes Inc.
Is the ownership direct or indirect?
The filing indicates the options are held directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.